Actualités et Analyses

Lonza and the next wave of healthcare solutions

May 5, 2026

Temps de lecture: 3:57 mins

Walter Scott’s John Rae assesses outsourced drugs manufacturer Lonza’s role in the healthcare ecosystem.

Key points:

Lonza’s role in the healthcare space is simliar to that of chip manufacturers in the semiconductor supply chain.
The company has high customer retention which creates resilient revenues.
It is investing heavily to support growth, including building manufacturing capacity in the US.
Walter Scott sees several quality healthcare businesses with high degrees of profitability, cash generation and low levels of debt.

3305309 Exp: 7 août 2026

Articles | Gestion Actions

Infrastructure: private vs. publicly listed

As private infrastructure markets face slower deal activity, elevated interest rates and growing levels of undeployed capital, investors may want to reassess where they seek infrastructure exposure.

Articles | Gestion Actions

Global equity income: built for this market

Global equity income may merit attention as inflation lingers, valuations stay stretched and investors seek more resilient, less correlated equity exposure.

Rapports | Macroéconomique

Monthly Checkpoints

Checkpoints is a comprehensive monthly chartbook highlighting major top-of-mind themes that could shape financial markets in the near term. In addition to the broader macroeconomic discussion, Checkpoints delivers detailed views on major asset classes, including global equities, fixed income and real assets.

Chart of the Week | Macroéconomique

Resilience is a historical trend

The S&P 500’s history shows that despite recessions, wars, inflation, and corrections, the market’s long-term trajectory has remained upward. As the U.S. marks 250 years of resilience, the lesson for investors is clear: wealth is built through patience, discipline and staying invested.